procaterol has been researched along with Weight Loss in 1 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
Weight Loss: Decrease in existing BODY WEIGHT.
Excerpt | Relevance | Reference |
---|---|---|
" Basal lipolysis, maximal lipolytic responses to isoprenaline (beta-AR agonist), dobutamine and procaterol (beta1- and beta2-AR agonists, respectively) as well as maximal antilipolytic effects of epinephrine or UK-14304 (alpha2-AR agonist) were similar before and after weight reduction." | 3.70 | Regional and gender variations in adipose tissue lipolysis in response to weight loss. ( Alméras, N; Després, JP; Imbeault, P; Lacaille, M; Langin, D; Mauriège, P; Tremblay, A, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mauriège, P | 1 |
Imbeault, P | 1 |
Langin, D | 1 |
Lacaille, M | 1 |
Alméras, N | 1 |
Tremblay, A | 1 |
Després, JP | 1 |
1 other study available for procaterol and Weight Loss
Article | Year |
---|---|
Regional and gender variations in adipose tissue lipolysis in response to weight loss.
Topics: Adenosine Deaminase; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Dob | 1999 |